Zobrazeno 1 - 10
of 42
pro vyhledávání: '"MOYI SUN"'
Autor:
Yi Li, Wei Guo, Xiuqin Li, Jianguo Zhang, Moyi Sun, Zhangui Tang, Wei Ran, Kai Yang, Guilin Huang, Longjiang Li
Publikováno v:
International Journal of Oral Science, Vol 13, Iss 1, Pp 1-6 (2021)
The first gene therapy product, recombinant adenovirus human p53 (rAd-p53), has been approved by CFDA since 2013. During these years, most of the clinical trials and the relevant basic research were carried out by Chinese oncologists. Gendicine was p
Externí odkaz:
https://doaj.org/article/d58a102c0f7349e89574158df0039104
Publikováno v:
Current Cancer Drug Targets. 22:603-616
Background: Salivary adenoid cystic carcinoma (SACC) is one of the most common malignant cancers of the salivary gland, and 32.4-72.0% of SACC cases exhibit neural invasion (NI); however, the molecular mechanism underlying the high invasion potential
Autor:
Houyu Ju, Jiawei Zheng, Moyi Sun, Zhangui Tang, Daoke Yang, Wei Ran, Zhijun Sun, Wei Shang, Jian Meng, Heming Wu, Qing Xi, Kai Yang, Jun Wang, Li Huang, Jiaxuan Qiu, Yunteng Wu, Guoxin Ren, Zhifei Dai, Wei Guo
Publikováno v:
Holistic Integrative Oncology. 2
Most of the patients with oral and maxillofacial malignancy are in the middle and advanced stages at diagnosis and the incidence rate is increasing in recent years. Chemotherapy alone is difficult to benefit the survival of patients with advanced ora
Autor:
Wei Guo, Jianguo Zhang, Yi Li, Guilin Huang, Moyi Sun, Longjiang Li, Kai Yang, Wei Ran, Xiuqin Li, Zhangui Tang
Publikováno v:
International Journal of Oral Science, Vol 13, Iss 1, Pp 1-6 (2021)
International Journal of Oral Science
International Journal of Oral Science
The first gene therapy product, recombinant adenovirus human p53 (rAd-p53), has been approved by CFDA since 2013. During these years, most of the clinical trials and the relevant basic research were carried out by Chinese oncologists. Gendicine was p
Autor:
Xia Yang, Wang Weiqi, Yaowu Yang, Janhua Wei, Zhiwei Yan, Wei Wu, Moyi Sun, Xinjie Yang, Xiangming Yang
Publikováno v:
Oral Surgery, Oral Medicine, Oral Pathology and Oral Radiology. 130:25-31
Objective The objectives of this study were to document the results of using fibrin glue (FG) combined with pingyangmycin (PYM) for the embolism and sclerotherapy of maxillofacial arteriovenous malformations (AVMs). Study Design We reviewed the assoc
Publikováno v:
Current cancer drug targets. 22(7)
Salivary adenoid cystic carcinoma (SACC) is one of the most common malignant cancers of the salivary gland, and 32.4-72.0% of SACC cases exhibit neural invasion (NI); however, the molecular mechanism underlying the high invasion potential of SACC rem
Autor:
Tao Gao, Chao Ma, Juan Chai, Xiangming Yang, Zhenyan Zhao, Zhang Yi, Qianwei Ni, Yun Li, Jun Ju, Moyi Sun
Publikováno v:
OncoTargets and Therapy. 12:1475-1495
Purpose Perineural invasion (PNI) is reported to correlate with local recurrence and poor prognosis of salivary adenoid cystic carcinoma (SACC). However, the pathogenesis of PNI remains unclear. The aims of this study were to investigate the correlat
Publikováno v:
Journal of Oral and Maxillofacial Surgery. 76:1708-1718
Perineural invasion (PNI) is a hallmark of salivary adenoid cystic carcinoma (SACC) and represents an important risk factor for local recurrence and poor survival. However, the mechanism of PNI has yet to be explored. We sought to examine the CCL5-CC
Publikováno v:
Journal of Oral and Maxillofacial Surgery. 76:569-579
We investigated the expression of neuropilin-1 (NRP1), neuropilin-2 (NRP2), vascular endothelial growth factor-A (VEGF-A), semaphorin-3A (Sema-3A), and semaphorin-3F (Sema-3F) in normal salivary gland (NSG) tissue, nonmetastatic salivary adenoid cyst
Autor:
Xiaoxiao Liu, Zhenyan Zhao, Tao Gao, Chao Ma, Juan Chai, Qianwei Ni, Moyi Sun, Yun Li, Jun Ju
Publikováno v:
Cancer Medicine
The aim of this study was to construct nomograms to predict long‐term overall survival (OS) and tongue cancer‐specific survival (TCSS) of tongue squamous cell carcinoma (TSCC) patients based on clinical and tumor characteristics. Clinical, tumor,